You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 214770


✉ Email this page to a colleague

« Back to Dashboard


NDA 214770 describes NOXAFIL POWDERMIX KIT, which is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. Additional details are available on the NOXAFIL POWDERMIX KIT profile page.

The generic ingredient in NOXAFIL POWDERMIX KIT is posaconazole. There are twenty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the posaconazole profile page.
Summary for 214770
Tradename:NOXAFIL POWDERMIX KIT
Applicant:Msd Merck Co
Ingredient:posaconazole
Patents:0
Pharmacology for NDA: 214770
Suppliers and Packaging for NDA: 214770
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NOXAFIL POWDERMIX KIT posaconazole FOR SUSPENSION, DELAYED RELEASE;ORAL 214770 NDA Merck Sharp & Dohme LLC 0085-2224 0085-2224-02 8 PACKET in 1 CARTON (0085-2224-02) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0085-2224-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION, DELAYED RELEASE;ORALStrength300MG
Approval Date:May 31, 2021TE:RLD:Yes
Regulatory Exclusivity Expiration:May 31, 2024
Regulatory Exclusivity Use:NEW PRODUCT

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.